Recent Analyst Forecasts and Stock Ratings
Entrada Therapeutics, Inc. FAQ's
Entrada Therapeutics, Inc. has been rated by research analysts at Roth Capital, H.C. Wainwright in the past 90 days.
Entrada Therapeutics, Inc. has been rated by research analysts at Roth Capital, H.C. Wainwright in the past 90 days.